Pharmacy Report Archives - Page 16 of 136 - Becker's Hospital Review

Ind. system opens $10M central pharmacy | HHS to lay off 10K workers | 10 systems seeking pharmacy leaders | Reciprocal tariffs: 5 details | 6 GLP-1 updates

March 27, 2025 BHR Newsletter 1. Indiana system launches automated central pharmacy Full story 2. Amazon Pharmacy executive exits Full story 3. 6 GLP-1 updates Full story 4. Hospitals are using tech to streamline IDR arbitration. See how, here. 5. HHS…

Oschner Children's targets Rx errors | 1st UTI antibiotic approved in 30 years | Specialty drug spend falls to 2nd place | A crossroads for GLP-1s | Gender pay gap shrinks

March 26, 2025 BHR Newsletter 1. Ochsner Children's, ISMP partner on pharmacist training, medication safety Full story 2. GLP-1s outpace specialty drug spend for the first time: Report Full story 3. FDA approves antibiotic to treat UTIs for 1st time in…

3 systems' strategy for ultrahigh-cost drugs | U of Calif. pharmacists to strike again | Will GLP-1 compounding stop? | Okla. system CEO, CFO resigns | 10 hospitals with longest ED visit times

March 25, 2025 BHR Newsletter 1. Health systems' strategy for ultrahigh-cost drugs Full story 2. Novo Nordisk expands access to reduced-cost Wegovy Full story 3. 10 most, least stressed states Full story 4. CommonSpirit, Duke + Ballad Health cracked the code…

6 innovators on leadership, growth | 8 deaths tied to drug plant | Novo strikes $2B deal for obesity drug | Why hospital closures are rising | 46% of healthcare execs eye exit

March 24, 2025 BHR Newsletter 1. 6 pharmacy visionaries on leadership and growth Full story 2. FDA finds cleaning, testing issues at drug plant linked to 8 deaths Full story 3. Novo Nordisk to pay up to $2B for experimental…

Big lessons for 12 pharmacy execs | Optum Rx alters pharmacy reimbursements | 10 systems seeking pharmacy leaders | A case for 340B spend audits | VCU fast-tracks PharmD path

March 20, 2025 BHR Newsletter 1. VCU launches accelerated PharmD program Full story 2. The case for auditing 340B spend Full story 3. Optum Rx's new payment model favors brand names over generics Full story 4. AI in the ED —…

Patient death linked to gene therapy | Ohio hospital pharmacy to close | ScionHealth + Mark Cuban: 3 details | Optum Rx drops some prior auths | Purdue to pay $7.4B for opioid crisis

March 19, 2025 BHR Newsletter 1. 1st patient death linked to muscular dystrophy treatment Full story 2. Struggling Ohio hospital's pharmacy to close Full story 3. Optum Rx to drop prior authorization for dozens of prescription drugs Full story 4.…

Merck to close Pa. plant | Wegovy, Zepbound not cost-effective: Study | HHS chimes in on 340B rebate case | CHS' top-earning execs | La. system rebrands

March 18, 2025 BHR Newsletter 1. Merck to lay off 163, shutter Pennsylvania plant Full story 2. HHS files brief in 340B rebate model case: 4 takeaways Full story 3. Zepbound, Wegovy fail to justify prices: Study Full story 4.…

CMS doubles down on drug price negotiations | How MetroHealth combats pharma deserts | New stroke drug beats decades-old treatment | Trump signs funding bill: What to know | 10 most, least overweight cities

March 17, 2025 BHR Newsletter 1. CMS doubles down on Medicare drug price negotiations Full story 2. How MetroHealth is expanding access in a pharmacy desert Full story 3. New stroke drug compares favorably to decades-old treatment: Study Full story 4. 45…

CMS cancels $2 drug plan | 10 drugs poised to be top-sellers | Trump drops CDC nominee | 10 systems seeking pharmacy leaders | Gene therapies 'tip of the iceberg': Children's National exec

March 13, 2025 BHR Newsletter 1. GOP House leaders block vote to end Trump tariffs: 4 things to know Full story 2. 10 drugs poised to be best-sellers in 2026 Full story 3. CMS cancels $2 generic drug plan Full story…

Civica Rx's 2025 plans | Hospitals shrug GPOs for drugmakers | Why Ozempic might slow aging | 6 most lucrative drug markets | Ohio hospital limits admissions

March 12, 2025 BHR Newsletter 1. Innovation despite 'white knuckle time' in healthcare Full story 2. Inside Civica Rx's 2025 sourcing, expansion strategies Full story 3. HIV drug could offer yearlong protection with a single shot Full story 4. More…